| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 2.65e-05 | 130 | 54 | 5 | GO:0005200 | |
| GeneOntologyBiologicalProcess | dense core granule docking | 6.23e-06 | 2 | 52 | 2 | GO:0061790 | |
| GeneOntologyBiologicalProcess | dense core granule priming | 3.73e-05 | 4 | 52 | 2 | GO:0061789 | |
| GeneOntologyCellularComponent | intercellular bridge | 4.39e-06 | 94 | 54 | 5 | GO:0045171 | |
| GeneOntologyCellularComponent | tubulin complex | 1.96e-05 | 3 | 54 | 2 | GO:0045298 | |
| GeneOntologyCellularComponent | presynaptic membrane | 7.77e-05 | 277 | 54 | 6 | GO:0042734 | |
| GeneOntologyCellularComponent | mitotic spindle | 1.69e-04 | 201 | 54 | 5 | GO:0072686 | |
| GeneOntologyCellularComponent | cell cortex region | 2.14e-04 | 45 | 54 | 3 | GO:0099738 | |
| GeneOntologyCellularComponent | cytoplasmic region | 3.22e-04 | 360 | 54 | 6 | GO:0099568 | |
| GeneOntologyCellularComponent | synaptic membrane | 7.20e-04 | 583 | 54 | 7 | GO:0097060 | |
| GeneOntologyCellularComponent | azurophil granule | 7.76e-04 | 160 | 54 | 4 | GO:0042582 | |
| GeneOntologyCellularComponent | primary lysosome | 7.76e-04 | 160 | 54 | 4 | GO:0005766 | |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 1.60e-03 | 23 | 54 | 2 | GO:0098831 | |
| Domain | Beta-tubulin_BS | 1.29e-08 | 10 | 54 | 4 | IPR013838 | |
| Domain | Beta_tubulin | 1.29e-08 | 10 | 54 | 4 | IPR002453 | |
| Domain | TUBULIN_B_AUTOREG | 2.03e-08 | 11 | 54 | 4 | PS00228 | |
| Domain | - | 2.92e-07 | 20 | 54 | 4 | 3.30.1330.20 | |
| Domain | - | 3.60e-07 | 21 | 54 | 4 | 1.10.287.600 | |
| Domain | Tubulin_C | 4.39e-07 | 22 | 54 | 4 | SM00865 | |
| Domain | Tubulin_C | 4.39e-07 | 22 | 54 | 4 | PF03953 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 4.39e-07 | 22 | 54 | 4 | IPR018316 | |
| Domain | - | 4.39e-07 | 22 | 54 | 4 | 3.40.50.1440 | |
| Domain | Tubulin_C | 5.30e-07 | 23 | 54 | 4 | IPR023123 | |
| Domain | TUBULIN | 5.30e-07 | 23 | 54 | 4 | PS00227 | |
| Domain | Tubulin | 5.30e-07 | 23 | 54 | 4 | IPR000217 | |
| Domain | Tub_FtsZ_C | 5.30e-07 | 23 | 54 | 4 | IPR008280 | |
| Domain | Tubulin | 5.30e-07 | 23 | 54 | 4 | SM00864 | |
| Domain | Tubulin_CS | 5.30e-07 | 23 | 54 | 4 | IPR017975 | |
| Domain | Tubulin_FtsZ_GTPase | 6.35e-07 | 24 | 54 | 4 | IPR003008 | |
| Domain | Tubulin | 6.35e-07 | 24 | 54 | 4 | PF00091 | |
| Domain | Unc-13 | 2.46e-05 | 3 | 54 | 2 | IPR027080 | |
| Domain | Munc13_dom-2 | 8.16e-05 | 5 | 54 | 2 | IPR014772 | |
| Domain | Membr_traf_MHD | 8.16e-05 | 5 | 54 | 2 | PF10540 | |
| Domain | MHD2 | 8.16e-05 | 5 | 54 | 2 | PS51259 | |
| Domain | Munc13_subgr_dom-2 | 8.16e-05 | 5 | 54 | 2 | IPR019558 | |
| Domain | DUF1041 | 8.16e-05 | 5 | 54 | 2 | SM01145 | |
| Domain | DUF1041 | 1.71e-04 | 7 | 54 | 2 | PF06292 | |
| Domain | Munc13_1 | 1.71e-04 | 7 | 54 | 2 | IPR014770 | |
| Domain | CAPS_dom | 1.71e-04 | 7 | 54 | 2 | IPR010439 | |
| Domain | MHD1 | 1.71e-04 | 7 | 54 | 2 | PS51258 | |
| Domain | PI3/4_kinase_CS | 8.41e-04 | 15 | 54 | 2 | IPR018936 | |
| Domain | - | 9.59e-04 | 16 | 54 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 9.59e-04 | 16 | 54 | 2 | SM00146 | |
| Domain | PI3/4_kinase_cat_dom | 1.22e-03 | 18 | 54 | 2 | IPR000403 | |
| Domain | PI3_PI4_kinase | 1.22e-03 | 18 | 54 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 1.22e-03 | 18 | 54 | 2 | PS50290 | |
| Domain | PI3_4_KINASE_1 | 1.22e-03 | 18 | 54 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 1.22e-03 | 18 | 54 | 2 | PS00916 | |
| Domain | TYR_PHOSPHATASE_2 | 2.04e-03 | 87 | 54 | 3 | PS50056 | |
| Domain | TYR_PHOSPHATASE_dom | 2.04e-03 | 87 | 54 | 3 | IPR000387 | |
| Domain | Cadherin_cytoplasmic-dom | 2.36e-03 | 25 | 54 | 2 | IPR000233 | |
| Domain | Cadherin_C | 2.36e-03 | 25 | 54 | 2 | PF01049 | |
| Domain | - | 2.39e-03 | 92 | 54 | 3 | 3.90.190.10 | |
| Domain | Prot-tyrosine_phosphatase-like | 2.95e-03 | 99 | 54 | 3 | IPR029021 | |
| Domain | Catenin_binding_dom | 3.17e-03 | 29 | 54 | 2 | IPR027397 | |
| Domain | - | 3.17e-03 | 29 | 54 | 2 | 4.10.900.10 | |
| Domain | CA | 4.49e-03 | 115 | 54 | 3 | SM00112 | |
| Domain | Cadherin | 4.82e-03 | 118 | 54 | 3 | IPR002126 | |
| Domain | PTPc | 4.85e-03 | 36 | 54 | 2 | SM00194 | |
| Domain | TYR_PHOSPHATASE_PTP | 5.68e-03 | 39 | 54 | 2 | PS50055 | |
| Domain | PTPase_domain | 6.26e-03 | 41 | 54 | 2 | IPR000242 | |
| Domain | Y_phosphatase | 6.26e-03 | 41 | 54 | 2 | PF00102 | |
| Domain | C2 | 6.44e-03 | 131 | 54 | 3 | PF00168 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 9.68e-08 | 43 | 38 | 5 | M47669 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 1.04e-07 | 17 | 38 | 4 | M47768 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 1.22e-07 | 45 | 38 | 5 | M47670 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 1.34e-07 | 18 | 38 | 4 | M47753 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.69e-07 | 19 | 38 | 4 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.69e-07 | 19 | 38 | 4 | M47813 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 2.11e-07 | 20 | 38 | 4 | M47890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 2.11e-07 | 20 | 38 | 4 | M47911 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 2.60e-07 | 21 | 38 | 4 | M47767 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 3.17e-07 | 22 | 38 | 4 | M47903 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 3.83e-07 | 23 | 38 | 4 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 3.83e-07 | 23 | 38 | 4 | M47900 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 4.59e-07 | 24 | 38 | 4 | M47671 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 4.59e-07 | 24 | 38 | 4 | M47700 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 5.45e-07 | 25 | 38 | 4 | M47775 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 5.45e-07 | 25 | 38 | 4 | M47710 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 6.43e-07 | 26 | 38 | 4 | M47672 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION | 8.77e-07 | 28 | 38 | 4 | M47898 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION | 1.74e-06 | 33 | 38 | 4 | M47901 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 2.21e-06 | 35 | 38 | 4 | M47774 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT | 5.14e-06 | 43 | 38 | 4 | M47773 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 1.20e-05 | 17 | 38 | 3 | MM14731 | |
| Pathway | WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 1.39e-05 | 55 | 38 | 4 | M39613 | |
| Pathway | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 1.49e-05 | 56 | 38 | 4 | M2333 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 2.32e-05 | 21 | 38 | 3 | M27067 | |
| Pathway | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | 3.08e-05 | 23 | 38 | 3 | M19135 | |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | 3.83e-05 | 71 | 38 | 4 | M39690 | |
| Pathway | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | 4.50e-05 | 26 | 38 | 3 | M9648 | |
| Pathway | WP_16P112_PROXIMAL_DELETION_SYNDROME | 5.01e-05 | 76 | 38 | 4 | M40057 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 5.05e-05 | 27 | 38 | 3 | MM15549 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 5.05e-05 | 27 | 38 | 3 | MM15674 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 6.29e-05 | 29 | 38 | 3 | MM15219 | |
| Pathway | REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS | 6.29e-05 | 29 | 38 | 3 | M27948 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 6.38e-05 | 261 | 38 | 6 | M42565 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 8.49e-05 | 32 | 38 | 3 | M29848 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 8.49e-05 | 32 | 38 | 3 | M27491 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 8.49e-05 | 32 | 38 | 3 | MM14730 | |
| Pathway | REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING | 9.32e-05 | 33 | 38 | 3 | M27297 | |
| Pathway | KEGG_GAP_JUNCTION | 9.71e-05 | 90 | 38 | 4 | M4013 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 9.71e-05 | 90 | 38 | 4 | MM14979 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 1.20e-04 | 95 | 38 | 4 | M6729 | |
| Pathway | REACTOME_AGGREPHAGY | 1.21e-04 | 36 | 38 | 3 | MM15669 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 1.32e-04 | 37 | 38 | 3 | MM15102 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 1.43e-04 | 38 | 38 | 3 | M14981 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 1.96e-04 | 202 | 38 | 5 | MM15362 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 2.06e-04 | 204 | 38 | 5 | M4217 | |
| Pathway | WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS | 2.16e-04 | 326 | 38 | 6 | M39379 | |
| Pathway | REACTOME_AGGREPHAGY | 2.22e-04 | 44 | 38 | 3 | M29830 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 2.22e-04 | 44 | 38 | 3 | MM14606 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 2.22e-04 | 44 | 38 | 3 | M27934 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 2.53e-04 | 46 | 38 | 3 | M27828 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 2.87e-04 | 48 | 38 | 3 | MM15353 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 3.06e-04 | 49 | 38 | 3 | M891 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 3.44e-04 | 51 | 38 | 3 | M26972 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 3.65e-04 | 52 | 38 | 3 | MM14949 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 3.65e-04 | 52 | 38 | 3 | MM15211 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 3.66e-04 | 127 | 38 | 4 | M27181 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 3.86e-04 | 53 | 38 | 3 | M27651 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 3.88e-04 | 129 | 38 | 4 | MM14894 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 4.08e-04 | 54 | 38 | 3 | M27482 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 4.78e-04 | 57 | 38 | 3 | M27251 | |
| Pathway | REACTOME_KINESINS | 4.78e-04 | 57 | 38 | 3 | MM15714 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 4.88e-04 | 137 | 38 | 4 | MM15182 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 5.29e-04 | 140 | 38 | 4 | M27550 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 5.44e-04 | 141 | 38 | 4 | MM15266 | |
| Pathway | REACTOME_KINESINS | 5.84e-04 | 61 | 38 | 3 | M977 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 6.86e-04 | 150 | 38 | 4 | M27440 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 7.36e-04 | 66 | 38 | 3 | MM17074 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 7.41e-04 | 411 | 38 | 6 | M735 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 7.69e-04 | 67 | 38 | 3 | MM15327 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 8.03e-04 | 68 | 38 | 3 | MM14921 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 8.03e-04 | 68 | 38 | 3 | MM14968 | |
| Pathway | REACTOME_AURKA_ACTIVATION_BY_TPX2 | 9.10e-04 | 71 | 38 | 3 | MM15495 | |
| Pathway | REACTOME_AURKA_ACTIVATION_BY_TPX2 | 9.48e-04 | 72 | 38 | 3 | M27749 | |
| Pathway | REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE | 9.48e-04 | 72 | 38 | 3 | M26954 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 9.87e-04 | 73 | 38 | 3 | MM15491 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 9.87e-04 | 73 | 38 | 3 | MM15672 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 1.11e-03 | 76 | 38 | 3 | M27215 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 1.11e-03 | 76 | 38 | 3 | M48037 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 1.24e-03 | 79 | 38 | 3 | M27743 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 1.30e-03 | 20 | 38 | 2 | M27290 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 1.30e-03 | 20 | 38 | 2 | MM15485 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 1.30e-03 | 20 | 38 | 2 | MM14991 | |
| Pathway | REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES | 1.33e-03 | 81 | 38 | 3 | M748 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 1.44e-03 | 21 | 38 | 2 | M27736 | |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | 1.47e-03 | 184 | 38 | 4 | MM15145 | |
| Pathway | REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION | 1.53e-03 | 85 | 38 | 3 | MM14906 | |
| Pathway | REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION | 1.64e-03 | 87 | 38 | 3 | M27194 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 1.68e-03 | 191 | 38 | 4 | M29614 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 1.75e-03 | 193 | 38 | 4 | MM14890 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 1.81e-03 | 90 | 38 | 3 | M29841 | |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | 1.99e-03 | 200 | 38 | 4 | M864 | |
| Pathway | REACTOME_CILIUM_ASSEMBLY | 2.03e-03 | 201 | 38 | 4 | M27472 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 2.05e-03 | 94 | 38 | 3 | M2843 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 2.05e-03 | 94 | 38 | 3 | MM14515 | |
| Pathway | REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE | 2.17e-03 | 96 | 38 | 3 | MM15207 | |
| Pathway | REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE | 2.24e-03 | 97 | 38 | 3 | M27478 | |
| Pathway | REACTOME_NEUTROPHIL_DEGRANULATION | 2.27e-03 | 511 | 38 | 6 | MM15330 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 2.30e-03 | 98 | 38 | 3 | MM15352 | |
| Pathway | REACTOME_PROTEIN_FOLDING | 2.30e-03 | 98 | 38 | 3 | M776 | |
| Pubmed | 7.76e-11 | 6 | 54 | 4 | 3782288 | ||
| Pubmed | Mutations in the β-tubulin gene TUBB5 cause microcephaly with structural brain abnormalities. | 3.62e-10 | 8 | 54 | 4 | 23246003 | |
| Pubmed | Tubulin beta 3 and 4 are involved in the generation of early fibrotic stages. | 3.54e-09 | 3 | 54 | 3 | 28648944 | |
| Pubmed | 1.22e-08 | 17 | 54 | 4 | 17360745 | ||
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 11120798 | ||
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 19545277 | ||
| Pubmed | 1.50e-08 | 50 | 54 | 5 | 23703321 | ||
| Pubmed | 3.05e-08 | 21 | 54 | 4 | 30110642 | ||
| Pubmed | Mitochondria-cytoskeleton interaction: distribution of β-tubulins in cardiomyocytes and HL-1 cells. | 3.53e-08 | 5 | 54 | 3 | 21296049 | |
| Pubmed | Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity. | 3.72e-08 | 22 | 54 | 4 | 23826228 | |
| Pubmed | Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression. | 3.72e-08 | 22 | 54 | 4 | 16526095 | |
| Pubmed | TUBB1 mutations cause thyroid dysgenesis associated with abnormal platelet physiology. | 3.72e-08 | 22 | 54 | 4 | 30446499 | |
| Pubmed | 7.05e-08 | 6 | 54 | 3 | 24275654 | ||
| Pubmed | 7.05e-08 | 6 | 54 | 3 | 18613978 | ||
| Pubmed | 1.38e-07 | 30 | 54 | 4 | 25864199 | ||
| Pubmed | 4.55e-07 | 40 | 54 | 4 | 30865227 | ||
| Pubmed | 4.65e-07 | 187 | 54 | 6 | 26460568 | ||
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | 5.74e-07 | 639 | 54 | 9 | 23443559 | |
| Pubmed | The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis. | 7.71e-07 | 12 | 54 | 3 | 15331610 | |
| Pubmed | ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection. | 8.85e-07 | 336 | 54 | 7 | 31253590 | |
| Pubmed | 8.90e-07 | 209 | 54 | 6 | 26389662 | ||
| Pubmed | HIV-1 rev depolymerizes microtubules to form stable bilayered rings. | 1.00e-06 | 13 | 54 | 3 | 10908577 | |
| Pubmed | 1.27e-06 | 14 | 54 | 3 | 12486001 | ||
| Pubmed | Quantitative interactome proteomics identifies a proteostasis network for GABAA receptors. | 1.52e-06 | 125 | 54 | 5 | 36030824 | |
| Pubmed | PEX14 is required for microtubule-based peroxisome motility in human cells. | 1.55e-06 | 54 | 54 | 4 | 21525035 | |
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 1.76e-06 | 235 | 54 | 6 | 28378594 | |
| Pubmed | Incorporation of dUTP does not mediate mutation of A:T base pairs in Ig genes in vivo. | 2.37e-06 | 2 | 54 | 2 | 20705648 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 17627938 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 12070347 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 12871971 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 17561838 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 23070049 | ||
| Pubmed | Differential distribution of beta-tubulin isotypes in cerebellum. | 2.37e-06 | 2 | 54 | 2 | 2461292 | |
| Pubmed | Heterodimerization of Munc13 C2A domain with RIM regulates synaptic vesicle docking and priming. | 2.37e-06 | 2 | 54 | 2 | 28489077 | |
| Pubmed | Munc13-1 is essential for fusion competence of glutamatergic synaptic vesicles. | 2.37e-06 | 2 | 54 | 2 | 10440375 | |
| Pubmed | Inhibition of exocytosis or endocytosis blocks activity-dependent redistribution of synapsin. | 2.37e-06 | 2 | 54 | 2 | 22066784 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 3459176 | ||
| Pubmed | Ultrastructural Correlates of Presynaptic Functional Heterogeneity in Hippocampal Synapses. | 2.37e-06 | 2 | 54 | 2 | 32187536 | |
| Pubmed | Molecular Mechanisms of Synaptic Vesicle Priming by Munc13 and Munc18. | 2.37e-06 | 2 | 54 | 2 | 28772123 | |
| Pubmed | Munc13-1 C1 domain activation lowers the energy barrier for synaptic vesicle fusion. | 2.37e-06 | 2 | 54 | 2 | 17267576 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 22814762 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 38031972 | ||
| Pubmed | Formation and Maintenance of Functional Spines in the Absence of Presynaptic Glutamate Release. | 2.37e-06 | 2 | 54 | 2 | 28426965 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 35613050 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 23770256 | ||
| Pubmed | Membrane bridging by Munc13-1 is crucial for neurotransmitter release. | 2.37e-06 | 2 | 54 | 2 | 30816091 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 28039326 | ||
| Pubmed | A common molecular basis for membrane docking and functional priming of synaptic vesicles. | 2.37e-06 | 2 | 54 | 2 | 19558619 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 18701688 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 6865944 | ||
| Pubmed | Calcium-Independent Exo-endocytosis Coupling at Small Central Synapses. | 2.37e-06 | 2 | 54 | 2 | 31851910 | |
| Pubmed | Differential control of vesicle priming and short-term plasticity by Munc13 isoforms. | 2.37e-06 | 2 | 54 | 2 | 11832228 | |
| Pubmed | Munc13 controls the location and efficiency of dense-core vesicle release in neurons. | 2.37e-06 | 2 | 54 | 2 | 23229896 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 11792326 | ||
| Pubmed | Roles of beta-tubulin residues Ala428 and Thr429 in microtubule formation in vivo. | 2.37e-06 | 2 | 54 | 2 | 19074767 | |
| Pubmed | Ascl1 (Mash1) knockout perturbs differentiation of nonneuronal cells in olfactory epithelium. | 2.84e-06 | 18 | 54 | 3 | 23284756 | |
| Pubmed | 3.36e-06 | 411 | 54 | 7 | 36652389 | ||
| Pubmed | 3.37e-06 | 19 | 54 | 3 | 15691386 | ||
| Pubmed | 3.37e-06 | 19 | 54 | 3 | 15698476 | ||
| Pubmed | 3.98e-06 | 809 | 54 | 9 | 32129710 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | 5.10e-06 | 1070 | 54 | 10 | 23533145 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TUBB3 TUBB4B PHLDB1 SETD1B DSG1 PIK3C2A TUBB MSH2 EIF3B CORO1B ALOX12B | 6.09e-06 | 1353 | 54 | 11 | 29467282 |
| Pubmed | 6.10e-06 | 166 | 54 | 5 | 34687317 | ||
| Pubmed | 6.85e-06 | 170 | 54 | 5 | 36470425 | ||
| Pubmed | Munc13- and SNAP25-dependent molecular bridges play a key role in synaptic vesicle priming. | 7.09e-06 | 3 | 54 | 2 | 37343100 | |
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 23658173 | ||
| Pubmed | β-Tubulin mutations that cause severe neuropathies disrupt axonal transport. | 7.09e-06 | 3 | 54 | 2 | 23503589 | |
| Pubmed | LAR receptor phospho-tyrosine phosphatases regulate NMDA-receptor responses. | 7.09e-06 | 3 | 54 | 2 | 31985401 | |
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 20139422 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 9784606 | ||
| Pubmed | Intact synapse structure and function after combined knockout of PTPδ, PTPσ, and LAR. | 7.09e-06 | 3 | 54 | 2 | 33656439 | |
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 17639022 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 33105896 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 22966208 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 15988013 | ||
| Pubmed | 7.94e-06 | 25 | 54 | 3 | 23562608 | ||
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 8.80e-06 | 179 | 54 | 5 | 36261009 | |
| Pubmed | Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes. | 9.13e-06 | 84 | 54 | 4 | 29563501 | |
| Pubmed | 1.26e-05 | 29 | 54 | 3 | 21360678 | ||
| Pubmed | 1.33e-05 | 711 | 54 | 8 | 33022573 | ||
| Pubmed | Transient, phorbol ester-induced DOC2-Munc13 interactions in vivo. | 1.42e-05 | 4 | 54 | 2 | 10488064 | |
| Pubmed | 1.42e-05 | 4 | 54 | 2 | 14967925 | ||
| Pubmed | Requirement for neuregulin receptor erbB2 in neural and cardiac development. | 1.42e-05 | 4 | 54 | 2 | 7477377 | |
| Pubmed | 1.42e-05 | 4 | 54 | 2 | 26231120 | ||
| Pubmed | 1.42e-05 | 4 | 54 | 2 | 6893015 | ||
| Pubmed | 1.42e-05 | 4 | 54 | 2 | 8524829 | ||
| Pubmed | Fbxo45, a novel ubiquitin ligase, regulates synaptic activity. | 1.42e-05 | 4 | 54 | 2 | 19996097 | |
| Pubmed | Munc13-1-mediated vesicle priming contributes to secretory amyloid precursor protein processing. | 1.42e-05 | 4 | 54 | 2 | 15123597 | |
| Pubmed | ELKS1 localizes the synaptic vesicle priming protein bMunc13-2 to a specific subset of active zones. | 1.42e-05 | 4 | 54 | 2 | 28264913 | |
| Pubmed | 1.42e-05 | 4 | 54 | 2 | 10588390 | ||
| Pubmed | 1.42e-05 | 4 | 54 | 2 | 8083744 | ||
| Pubmed | 1.42e-05 | 4 | 54 | 2 | 18619852 | ||
| Pubmed | HEY1 functions are regulated by its phosphorylation at Ser-68. | 1.49e-05 | 95 | 54 | 4 | 27129302 | |
| Pubmed | 1.60e-05 | 346 | 54 | 6 | 25324306 | ||
| Pubmed | 1.75e-05 | 99 | 54 | 4 | 29676259 | ||
| Pubmed | TUBB3 TUBB4B PIK3C2A TUBB TAF15 MSH2 EIF3B CORO1B CBFB DNAH1 | 1.93e-05 | 1247 | 54 | 10 | 27684187 | |
| Pubmed | 1.99e-05 | 212 | 54 | 5 | 23463506 | ||
| Pubmed | 2.13e-05 | 215 | 54 | 5 | 36808153 | ||
| Pubmed | 2.24e-05 | 35 | 54 | 3 | 22337587 | ||
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 2.33e-05 | 219 | 54 | 5 | 31353912 | |
| Interaction | TPSB2 interactions | 1.17e-07 | 18 | 52 | 4 | int:TPSB2 | |
| Interaction | KLK5 interactions | 3.62e-07 | 109 | 52 | 6 | int:KLK5 | |
| Interaction | CAPS interactions | 4.79e-07 | 25 | 52 | 4 | int:CAPS | |
| Interaction | ZC2HC1B interactions | 7.71e-07 | 28 | 52 | 4 | int:ZC2HC1B | |
| Interaction | BAGE2 interactions | 1.00e-06 | 70 | 52 | 5 | int:BAGE2 | |
| Interaction | VAV1 interactions | 1.88e-06 | 228 | 52 | 7 | int:VAV1 | |
| Interaction | TUBB8B interactions | 2.63e-06 | 11 | 52 | 3 | int:TUBB8B | |
| Interaction | AIRE interactions | 5.06e-06 | 97 | 52 | 5 | int:AIRE | |
| Interaction | TMPRSS5 interactions | 7.05e-06 | 48 | 52 | 4 | int:TMPRSS5 | |
| Interaction | CUL2 interactions | 1.80e-05 | 591 | 52 | 9 | int:CUL2 | |
| Interaction | HAUS2 interactions | 1.81e-05 | 126 | 52 | 5 | int:HAUS2 | |
| Interaction | TTC5 interactions | 2.37e-05 | 65 | 52 | 4 | int:TTC5 | |
| Interaction | ASB17 interactions | 3.58e-05 | 25 | 52 | 3 | int:ASB17 | |
| Interaction | MAGED2 interactions | 3.70e-05 | 243 | 52 | 6 | int:MAGED2 | |
| Interaction | TCP11L1 interactions | 4.18e-05 | 75 | 52 | 4 | int:TCP11L1 | |
| Interaction | GABRA1 interactions | 4.46e-05 | 152 | 52 | 5 | int:GABRA1 | |
| Interaction | GAN interactions | 4.63e-05 | 253 | 52 | 6 | int:GAN | |
| Interaction | OSTM1 interactions | 5.39e-05 | 80 | 52 | 4 | int:OSTM1 | |
| Interaction | GLMP interactions | 6.53e-05 | 84 | 52 | 4 | int:GLMP | |
| Interaction | IL12RB1 interactions | 7.49e-05 | 87 | 52 | 4 | int:IL12RB1 | |
| Interaction | ZUP1 interactions | 8.48e-05 | 174 | 52 | 5 | int:ZUP1 | |
| Interaction | PRKCZ interactions | 8.58e-05 | 412 | 52 | 7 | int:PRKCZ | |
| Interaction | ASB4 interactions | 9.16e-05 | 34 | 52 | 3 | int:ASB4 | |
| Interaction | METTL3 interactions | 9.30e-05 | 287 | 52 | 6 | int:METTL3 | |
| Interaction | PPFIA2 interactions | 1.18e-04 | 37 | 52 | 3 | int:PPFIA2 | |
| Interaction | TTI1 interactions | 1.34e-04 | 101 | 52 | 4 | int:TTI1 | |
| Interaction | TUBB2A interactions | 1.57e-04 | 316 | 52 | 6 | int:TUBB2A | |
| Interaction | DNASE2B interactions | 1.99e-04 | 44 | 52 | 3 | int:DNASE2B | |
| Interaction | TES interactions | 2.05e-04 | 332 | 52 | 6 | int:TES | |
| Interaction | PRRT2 interactions | 2.54e-04 | 220 | 52 | 5 | int:PRRT2 | |
| Interaction | WNT7A interactions | 2.58e-04 | 48 | 52 | 3 | int:WNT7A | |
| Interaction | SOCS7 interactions | 2.75e-04 | 49 | 52 | 3 | int:SOCS7 | |
| Interaction | PPEF1 interactions | 3.28e-04 | 52 | 52 | 3 | int:PPEF1 | |
| Interaction | CBL interactions | 3.42e-04 | 516 | 52 | 7 | int:CBL | |
| Interaction | PEX14 interactions | 3.57e-04 | 237 | 52 | 5 | int:PEX14 | |
| Interaction | RSPH1 interactions | 3.63e-04 | 131 | 52 | 4 | int:RSPH1 | |
| Interaction | ARL2 interactions | 3.73e-04 | 132 | 52 | 4 | int:ARL2 | |
| Interaction | DDB1 interactions | 3.85e-04 | 697 | 52 | 8 | int:DDB1 | |
| Interaction | TUBB4A interactions | 4.08e-04 | 244 | 52 | 5 | int:TUBB4A | |
| Interaction | KCNH5 interactions | 4.24e-04 | 12 | 52 | 2 | int:KCNH5 | |
| Interaction | RPGR interactions | 4.30e-04 | 57 | 52 | 3 | int:RPGR | |
| Interaction | PPFIA3 interactions | 4.30e-04 | 57 | 52 | 3 | int:PPFIA3 | |
| Interaction | TUBG1 interactions | 4.35e-04 | 382 | 52 | 6 | int:TUBG1 | |
| Interaction | USP11 interactions | 4.44e-04 | 539 | 52 | 7 | int:USP11 | |
| Interaction | FBXO6 interactions | 4.65e-04 | 717 | 52 | 8 | int:FBXO6 | |
| Interaction | CDC42 interactions | TUBB3 TUBB4A TUBB4B IRS4 PTPRF DSG1 PIK3C2A PTPRS TUBB MSH2 STOM | 4.65e-04 | 1323 | 52 | 11 | int:CDC42 |
| Interaction | HEY1 interactions | 4.66e-04 | 140 | 52 | 4 | int:HEY1 | |
| Interaction | LINC01554 interactions | 4.92e-04 | 142 | 52 | 4 | int:LINC01554 | |
| Interaction | USP18 interactions | 5.00e-04 | 60 | 52 | 3 | int:USP18 | |
| Interaction | OMG interactions | 5.00e-04 | 13 | 52 | 2 | int:OMG | |
| Interaction | MAPK7 interactions | 5.05e-04 | 143 | 52 | 4 | int:MAPK7 | |
| Interaction | ALKBH3 interactions | 5.25e-04 | 61 | 52 | 3 | int:ALKBH3 | |
| Interaction | ITLN1 interactions | 5.25e-04 | 61 | 52 | 3 | int:ITLN1 | |
| Interaction | RPS6KB2 interactions | 5.54e-04 | 261 | 52 | 5 | int:RPS6KB2 | |
| Interaction | AMBRA1 interactions | 5.94e-04 | 265 | 52 | 5 | int:AMBRA1 | |
| Interaction | CUL5 interactions | 6.00e-04 | 567 | 52 | 7 | int:CUL5 | |
| Interaction | CDK13 interactions | 6.51e-04 | 153 | 52 | 4 | int:CDK13 | |
| Interaction | ARHGEF7 interactions | 6.51e-04 | 153 | 52 | 4 | int:ARHGEF7 | |
| Interaction | CAPSL interactions | 6.71e-04 | 15 | 52 | 2 | int:CAPSL | |
| Interaction | CDHR4 interactions | 7.21e-04 | 68 | 52 | 3 | int:CDHR4 | |
| Interaction | MAP2K2 interactions | 7.37e-04 | 278 | 52 | 5 | int:MAP2K2 | |
| Interaction | OPTC interactions | 7.66e-04 | 16 | 52 | 2 | int:OPTC | |
| Interaction | FAM86B2 interactions | 7.66e-04 | 16 | 52 | 2 | int:FAM86B2 | |
| Interaction | EFNA2 interactions | 8.18e-04 | 71 | 52 | 3 | int:EFNA2 | |
| Interaction | CEP250 interactions | 8.51e-04 | 287 | 52 | 5 | int:CEP250 | |
| GeneFamily | Tubulins | 1.34e-07 | 26 | 33 | 4 | 778 | |
| GeneFamily | UNC13 homologs | 1.93e-05 | 4 | 33 | 2 | 836 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 6.64e-04 | 21 | 33 | 2 | 813 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.11e-03 | 161 | 33 | 3 | 593 | |
| GeneFamily | RNA binding motif containing | 6.78e-03 | 213 | 33 | 3 | 725 | |
| GeneFamily | Fibronectin type III domain containing | 3.44e-02 | 160 | 33 | 2 | 555 | |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G4 | 9.19e-06 | 20 | 54 | 3 | M10885 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 3.88e-07 | 61 | 52 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500 | 2.85e-06 | 495 | 52 | 9 | Facebase_RNAseq_e10.5_Olfactory Pit_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 3.50e-06 | 169 | 52 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_100 | 4.35e-06 | 99 | 52 | 5 | Facebase_RNAseq_e8.5_Floor Plate_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500_k-means-cluster#2 | 1.32e-05 | 59 | 52 | 4 | Facebase_RNAseq_e10.5_Olfactory Pit_500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000 | TUBB3 FREM2 TUBB4A SORBS2 CMIP IRS4 PPP2R5D SCUBE2 PIK3C2A FEZF1 TAF15 | 2.31e-05 | 994 | 52 | 11 | Facebase_RNAseq_e8.5_Floor Plate_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_100 | 9.74e-05 | 98 | 52 | 4 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | UNC13B IGSF10 TUBB3 FREM2 TUBB4A SORBS2 CMIP IRS4 PTPRF FEZF1 | 1.17e-04 | 984 | 52 | 10 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | UNC13B FREM2 TUBB4A SORBS2 IRS4 SCUBE2 FEZF1 TUBB CKAP2L TAF15 | 1.22e-04 | 989 | 52 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.23e-04 | 104 | 52 | 4 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#2 | 1.38e-04 | 41 | 52 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.60e-04 | 334 | 52 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_500 | 1.80e-04 | 489 | 52 | 7 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_500 | 1.94e-04 | 495 | 52 | 7 | Facebase_RNAseq_e8.5_Floor Plate_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | 2.01e-04 | 498 | 52 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 | |
| CoexpressionAtlas | thyroid gland | 2.98e-04 | 240 | 52 | 5 | thyroid gland | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#1 | 4.38e-04 | 145 | 52 | 4 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_500_K1 | |
| CoexpressionAtlas | e10.5_NeuroEpith_MedialEmin_top-relative-expression-ranked_500_5 | 4.51e-04 | 13 | 52 | 2 | Facebase_ST1_e10.5_NeuroEpith_MedialEmin_500_5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#1 | 5.91e-04 | 157 | 52 | 4 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500_K1 | |
| CoexpressionAtlas | dev gonad_e13.5_M_SertoliCell_Sox9_k-means-cluster#4_top-relative-expression-ranked_100 | 6.05e-04 | 15 | 52 | 2 | gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_k4_100 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 4.37e-06 | 200 | 54 | 5 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | LPS-antiTNF-Endothelial-Mes-Like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.04e-05 | 158 | 54 | 4 | 50df52d64d07178975563abd98ce4fddb9f2f7ef | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Secretory/RAS|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.37e-05 | 170 | 54 | 4 | b62f7184e78e9672ea88e361654f604f9df2dc5f | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.37e-05 | 170 | 54 | 4 | 00fe77bca9c28762212c498f9c49e14cb1492cca | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.49e-05 | 171 | 54 | 4 | d6114db2292fbb27b39d090d51fd305a135b1ccf | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.49e-05 | 171 | 54 | 4 | 05014cf6746e6663e376fdd681f1b43a7081c603 | |
| ToppCell | IIH-mDC1-|IIH / Condition, Cell_class and T cell subcluster | 6.14e-05 | 176 | 54 | 4 | bb80a3e595d071f6cc8b042984b8d9490e377eef | |
| ToppCell | IIH-mDC1|IIH / Condition, Cell_class and T cell subcluster | 6.14e-05 | 176 | 54 | 4 | a75dc132a1061006fd1cb305bd314784fca07ea6 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Smooth_muscle_cells|Fibroblasts / Location, Cell class and cell subclass | 6.56e-05 | 179 | 54 | 4 | 83506e00fe99b6450efd2f13f716926a0a4b03cd | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.61e-05 | 186 | 54 | 4 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.77e-05 | 187 | 54 | 4 | db2974e2e87ac9f1c2407a371d5ed89af09fc9b7 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.93e-05 | 188 | 54 | 4 | 9858940c616e43441644c5a3bea8d832ee4daf79 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 7.93e-05 | 188 | 54 | 4 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.26e-05 | 190 | 54 | 4 | 625c08a0e5227efc46daa512fd579c3938ff76c7 | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.43e-05 | 191 | 54 | 4 | 6e6b2cb390cc5cd0356924a2c36fbe5b5bd5966c | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.43e-05 | 191 | 54 | 4 | 482db995930346be69072ace2fd78fd453e97fb5 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.60e-05 | 192 | 54 | 4 | b7c01e12b3e9be960a741b08835f1dfff65d0d47 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 8.60e-05 | 192 | 54 | 4 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | P15-Endothelial-large_vessel_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.78e-05 | 193 | 54 | 4 | 5f9a7cd5f8eb9ac294cdb50518fedf872f3f78f5 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.78e-05 | 193 | 54 | 4 | 4b8202fcfe639a73f69a13f48fc3601ade256346 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.32e-05 | 196 | 54 | 4 | 4924a36a81d62863c1004b8c76f8096a1f89c548 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.32e-05 | 196 | 54 | 4 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | 10x5'v1-week_17-19|World / cell types per 3 fetal stages;per 3',per 5' | 9.32e-05 | 196 | 54 | 4 | 31229affb48521e8be93b6061178fd8cea09ba99 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-Sox9_Epi-Sox9_Epi_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.50e-05 | 197 | 54 | 4 | 6de02b02fcdfcab1c1b0f4a4c75677410bc55688 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.69e-05 | 198 | 54 | 4 | 8aa4149d2c1cec73cfd654db093252ec8ec5ef68 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.69e-05 | 198 | 54 | 4 | c3dd887c95587f930b7afd32385627a9fa029ca4 | |
| ToppCell | wk_08-11-Epithelial-Distal_epithelial_progenitor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.69e-05 | 198 | 54 | 4 | eda85a592527992b51a00f288cff0c3239c47e6f | |
| ToppCell | wk_08-11-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.69e-05 | 198 | 54 | 4 | 84697f316d9195ebe838cf57f4dbdd9feea43bec | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.88e-05 | 199 | 54 | 4 | 5478b78349b5d8d57f30bb650dcbd5fdb84283d6 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10-Neuronal|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 9.88e-05 | 199 | 54 | 4 | b2508bf591720830e8e3494b1337aab14539956d | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal-Neurons|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 9.88e-05 | 199 | 54 | 4 | ae575ed7582f2a4218f6cbcbf5f7f0ce7a5bc26b | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10-Neuronal-Neurons|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 9.88e-05 | 199 | 54 | 4 | 0c5a5fbb174a013be10961f0db65c65c797ab4af | |
| ToppCell | 390C-Endothelial_cells-Endothelial-A_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-04 | 200 | 54 | 4 | 50b8788494b744e0f0ec8c4d67a1c90ae09dca65 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-A_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-04 | 200 | 54 | 4 | f5f24273bee3259a4a3be99ba53b88defa1286c0 | |
| Drug | Epothilone D | 1.28e-08 | 12 | 53 | 4 | DB01873 | |
| Drug | Epothilone B | 1.28e-08 | 12 | 53 | 4 | DB03010 | |
| Drug | ABT-751 | 5.71e-08 | 44 | 53 | 5 | CID003035714 | |
| Drug | bromocolchicine | 1.52e-07 | 21 | 53 | 4 | CID000161518 | |
| Drug | Ustiloxin A | 1.52e-07 | 21 | 53 | 4 | CID000164454 | |
| Drug | SRI-3072 | 1.52e-07 | 21 | 53 | 4 | CID000493469 | |
| Drug | colchifoline | 1.52e-07 | 21 | 53 | 4 | CID000100132 | |
| Drug | 3,4,5-trimethoxyacetophenone | 1.86e-07 | 22 | 53 | 4 | CID000014345 | |
| Drug | AC1L1GIQ | 1.86e-07 | 22 | 53 | 4 | CID000003700 | |
| Drug | 2,4-dichlorobenzyl thiocyanate | 1.86e-07 | 22 | 53 | 4 | CID000098538 | |
| Drug | SureCN13401588 | 1.86e-07 | 22 | 53 | 4 | CID009897422 | |
| Drug | N-methyldemecolcine | 1.86e-07 | 22 | 53 | 4 | CID000023759 | |
| Drug | NSC-339672 | 1.86e-07 | 22 | 53 | 4 | CID000433930 | |
| Drug | IKP104 | 2.24e-07 | 23 | 53 | 4 | CID000130739 | |
| Drug | fluorescein-colchicine | 2.24e-07 | 23 | 53 | 4 | CID003035871 | |
| Drug | 3,4,5-trimethoxybenzaldehyde | 2.24e-07 | 23 | 53 | 4 | CID000006858 | |
| Drug | 3-demethylthiocolchicine | 2.24e-07 | 23 | 53 | 4 | CID000084076 | |
| Drug | 2,3,4-TCB | 2.24e-07 | 23 | 53 | 4 | CID000129239 | |
| Drug | AC1L2P05 | 2.24e-07 | 23 | 53 | 4 | CID000125688 | |
| Drug | 2,3,4-tabp | 2.24e-07 | 23 | 53 | 4 | CID000125548 | |
| Drug | NSC-373301 | 2.24e-07 | 23 | 53 | 4 | CID000341375 | |
| Drug | N-acetylcolchinol | 2.24e-07 | 23 | 53 | 4 | CID000097865 | |
| Drug | NSC355636 | 2.24e-07 | 23 | 53 | 4 | CID000100176 | |
| Drug | moscatilin | 2.69e-07 | 24 | 53 | 4 | CID000176096 | |
| Drug | parbendazole | 2.69e-07 | 24 | 53 | 4 | CID000026596 | |
| Drug | NSC-36768 | 2.69e-07 | 24 | 53 | 4 | CID000165441 | |
| Drug | deacetamidocolchicine | 2.69e-07 | 24 | 53 | 4 | CID000014995 | |
| Drug | tropolone methyl ether | 2.69e-07 | 24 | 53 | 4 | CID000016546 | |
| Drug | 7-epi-cephalomannine | 2.69e-07 | 24 | 53 | 4 | CID000330401 | |
| Drug | NABV | 2.69e-07 | 24 | 53 | 4 | CID000175959 | |
| Drug | colchicide | 2.69e-07 | 24 | 53 | 4 | CID000120712 | |
| Drug | AC1L4TG7 | 2.69e-07 | 24 | 53 | 4 | CID000163705 | |
| Drug | NBD-colcemid | 3.19e-07 | 25 | 53 | 4 | CID000130594 | |
| Drug | mpMap | 3.19e-07 | 25 | 53 | 4 | CID000100806 | |
| Drug | AC1Q6P06 | 3.19e-07 | 25 | 53 | 4 | CID000160263 | |
| Drug | 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone | 3.19e-07 | 25 | 53 | 4 | CID000043264 | |
| Drug | allocolchicine | 3.19e-07 | 25 | 53 | 4 | CID000196989 | |
| Drug | 1069C85 | 3.19e-07 | 25 | 53 | 4 | CID006918099 | |
| Drug | 55623-37-5 | 3.19e-07 | 25 | 53 | 4 | CID006438440 | |
| Drug | CA1P | 3.19e-07 | 25 | 53 | 4 | CID006918545 | |
| Drug | peloruside A | 3.19e-07 | 25 | 53 | 4 | CID006918506 | |
| Drug | NSC142227 | 3.19e-07 | 25 | 53 | 4 | CID000073427 | |
| Drug | MDL 27048 | 3.19e-07 | 25 | 53 | 4 | CID006439188 | |
| Drug | NSC527981 | 3.77e-07 | 26 | 53 | 4 | CID000352796 | |
| Drug | NSC332029 | 3.77e-07 | 26 | 53 | 4 | CID000100073 | |
| Drug | indibulin | 3.77e-07 | 26 | 53 | 4 | CID000002929 | |
| Drug | pironetin | 3.77e-07 | 26 | 53 | 4 | CID006438891 | |
| Drug | isaxonine | 3.77e-07 | 26 | 53 | 4 | CID000071169 | |
| Drug | AC1L1J4H | 4.41e-07 | 27 | 53 | 4 | CID000004862 | |
| Drug | NSC292222 | 4.41e-07 | 27 | 53 | 4 | CID000099957 | |
| Drug | dinitroanilines | 4.41e-07 | 27 | 53 | 4 | CID000136400 | |
| Drug | NSC D-669356 | 4.41e-07 | 27 | 53 | 4 | CID000178028 | |
| Drug | NSC 370147 | 5.14e-07 | 28 | 53 | 4 | CID000182762 | |
| Drug | NSC72302 | 5.14e-07 | 28 | 53 | 4 | CID000118078 | |
| Drug | bp U | 5.95e-07 | 29 | 53 | 4 | CID000368697 | |
| Drug | Aids106696 | 5.95e-07 | 29 | 53 | 4 | CID006475933 | |
| Drug | ddGDP | 5.95e-07 | 29 | 53 | 4 | CID000134739 | |
| Drug | oxibendazole | 5.95e-07 | 29 | 53 | 4 | CID000004622 | |
| Drug | AC1NBBHE | 6.86e-07 | 30 | 53 | 4 | CID004490620 | |
| Drug | eleutherobin | 6.86e-07 | 30 | 53 | 4 | CID006918335 | |
| Drug | azatoxin | 6.86e-07 | 30 | 53 | 4 | CID000125383 | |
| Drug | NSC617668 | 6.86e-07 | 30 | 53 | 4 | CID000357989 | |
| Drug | citostal | 6.86e-07 | 30 | 53 | 4 | CID000018991 | |
| Drug | thiocolchicine | 6.86e-07 | 30 | 53 | 4 | CID000017648 | |
| Drug | tropone | 7.86e-07 | 31 | 53 | 4 | CID000010881 | |
| Drug | NSC609395 | 7.86e-07 | 31 | 53 | 4 | CID005488798 | |
| Drug | amiprophosmethyl | 7.86e-07 | 31 | 53 | 4 | CID000100524 | |
| Drug | AC7700 | 7.86e-07 | 31 | 53 | 4 | CID006918404 | |
| Drug | 3,4-dimethylhexane-2,5-dione | 7.86e-07 | 31 | 53 | 4 | CID000032851 | |
| Drug | AC1L3V8I | 7.86e-07 | 31 | 53 | 4 | CID000122777 | |
| Drug | NSC332598 | 7.86e-07 | 31 | 53 | 4 | CID000615942 | |
| Drug | N,N'-ethylenebis(iodoacetamide | 7.86e-07 | 31 | 53 | 4 | CID000023678 | |
| Drug | AC1L1G95 | 8.96e-07 | 32 | 53 | 4 | CID000003583 | |
| Drug | E2-3,4-Q | 8.96e-07 | 32 | 53 | 4 | CID000067402 | |
| Drug | NSC153858 | 8.96e-07 | 32 | 53 | 4 | CID000547450 | |
| Drug | 2-demethylcolchicine | 8.96e-07 | 32 | 53 | 4 | CID000023757 | |
| Drug | CA4P | 1.02e-06 | 33 | 53 | 4 | CID000370232 | |
| Drug | taltobulin | 1.02e-06 | 33 | 53 | 4 | CID006918637 | |
| Drug | mebendazole | 1.02e-06 | 33 | 53 | 4 | CID000004030 | |
| Drug | triethyllead | 1.15e-06 | 34 | 53 | 4 | CID006328106 | |
| Drug | NSC376450 | 1.15e-06 | 34 | 53 | 4 | CID000005605 | |
| Drug | 2-phenyl-4-quinolone | 1.15e-06 | 34 | 53 | 4 | CID000161091 | |
| Drug | discodermolide | 1.30e-06 | 35 | 53 | 4 | CID000643668 | |
| Drug | AC1O5Y0F | 1.63e-06 | 37 | 53 | 4 | CID006442852 | |
| Drug | DTAF | 1.63e-06 | 37 | 53 | 4 | CID000123934 | |
| Drug | albendazole | 1.63e-06 | 37 | 53 | 4 | CID000002082 | |
| Drug | baccatin III | 1.63e-06 | 37 | 53 | 4 | CID000065366 | |
| Drug | laulimalide | 1.82e-06 | 38 | 53 | 4 | CID006918457 | |
| Drug | gnoscopine | 1.82e-06 | 38 | 53 | 4 | CID000004544 | |
| Drug | colchiceine | 1.82e-06 | 38 | 53 | 4 | CID000010156 | |
| Drug | erianin | 2.03e-06 | 39 | 53 | 4 | CID000356759 | |
| Drug | Dolastatin 10 | 2.03e-06 | 39 | 53 | 4 | CID000100208 | |
| Drug | AC1L8GZ1 | 2.25e-06 | 40 | 53 | 4 | CID000381235 | |
| Drug | indanone | 2.49e-06 | 41 | 53 | 4 | CID000006735 | |
| Drug | amoebal | 2.49e-06 | 41 | 53 | 4 | CID000001985 | |
| Drug | lumicolchicine | 2.49e-06 | 41 | 53 | 4 | CID000072624 | |
| Drug | AC1L9CY0 | 3.02e-06 | 43 | 53 | 4 | CID000396644 | |
| Drug | Stylophorin | 3.02e-06 | 43 | 53 | 4 | CID000010147 | |
| Drug | A805480 | 3.31e-06 | 44 | 53 | 4 | CID000620368 | |
| Drug | methyl ether | 3.63e-06 | 45 | 53 | 4 | CID000008254 | |
| Disease | facial paralysis (implicated_via_orthology) | 1.93e-09 | 10 | 53 | 4 | DOID:13934 (implicated_via_orthology) | |
| Disease | complex cortical dysplasia with other brain malformations 7 (implicated_via_orthology) | 1.93e-09 | 10 | 53 | 4 | DOID:0090132 (implicated_via_orthology) | |
| Disease | ptosis (implicated_via_orthology) | 1.93e-09 | 10 | 53 | 4 | DOID:0060260 (implicated_via_orthology) | |
| Disease | tubulinopathy (implicated_via_orthology) | 1.93e-09 | 10 | 53 | 4 | DOID:0112227 (implicated_via_orthology) | |
| Disease | cerebellar ataxia, mental retardation and dysequlibrium syndrome (implicated_via_orthology) | 4.54e-09 | 12 | 53 | 4 | DOID:0050997 (implicated_via_orthology) | |
| Disease | hypokalemic periodic paralysis (implicated_via_orthology) | 3.04e-07 | 8 | 53 | 3 | DOID:14452 (implicated_via_orthology) | |
| Disease | alpha wave measurement, electroencephalogram measurement | 1.41e-04 | 10 | 53 | 2 | EFO_0004357, EFO_0006870 | |
| Disease | handedness | 9.26e-04 | 106 | 53 | 3 | EFO_0009902 | |
| Disease | azoospermia (implicated_via_orthology) | 1.08e-03 | 27 | 53 | 2 | DOID:14227 (implicated_via_orthology) | |
| Disease | lipoprotein A measurement | 1.09e-03 | 112 | 53 | 3 | EFO_0006925 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ITFFRMKVQELQSPP | 976 | Q9UPW8 | |
| VVNSSVMVKFLFPRP | 356 | P11597 | |
| VTNFEIFRMREKQVP | 541 | P55884 | |
| RERPRSMVVIEVFTP | 251 | Q8IY22 | |
| EPIVMTVPRKSDLFQ | 346 | Q9BR76 | |
| IEPSEFSKVMEPLFR | 391 | Q14738 | |
| PVVPEKAVRFSFTIM | 616 | P15918 | |
| NIIKVSFATRRPEFM | 311 | Q92804 | |
| PDVTTLPRNVMFVFF | 316 | Q92542 | |
| TPEPFDSETRKVIQM | 411 | Q9NSY0 | |
| FPDTVFETRRPQVMK | 1631 | Q5SZK8 | |
| MERIVLQVDFPSPAF | 831 | O00443 | |
| MPRVVPDQRSKFENE | 1 | Q13951 | |
| EDLFQRFPRTPMSVE | 136 | Q7L5L3 | |
| FKIIRQEPSDSPMFI | 196 | Q02413 | |
| VKESFFRPILTVPQM | 971 | Q86Y13 | |
| KDPVEMRRINFQTPD | 1336 | Q13332 | |
| FKVMFEAPSELTQRP | 4146 | Q9P2D7 | |
| FQSRPPITVRTMIKD | 916 | Q6WRI0 | |
| KFNELMVTFRVRPTV | 96 | Q99807 | |
| TFQDEMVLPRRPSEV | 926 | Q86WZ0 | |
| TRIPDKFPVTDDMVA | 281 | O75342 | |
| RPSTPKEMFITVEFE | 546 | Q9NQ36 | |
| DVMPETIFQIRRTVP | 691 | Q9ULB4 | |
| RFFQGMPEKPTTTVR | 21 | P43246 | |
| RTMPVEQVFAKNFRV | 1006 | P10586 | |
| DEMLFTRRFVTPSEP | 391 | O14654 | |
| VRPVSNFPTDKFMTV | 256 | Q8NH83 | |
| PPRVVTFDEVMATAR | 56 | Q8N4U5 | |
| FSIERIMARTPEPKA | 31 | A0PJY2 | |
| RVPEKVPFRMTQNIE | 2366 | Q96Q15 | |
| IPMSREFTPETERQR | 291 | Q5JR12 | |
| QPLFRPRSEFEEMTI | 1666 | Q9UPS6 | |
| PVENIIRFFPMTKEF | 91 | Q8WUJ0 | |
| VPRDMVPTRISEFEK | 501 | O94875 | |
| FIKVDMRTISFDIPP | 91 | P27105 | |
| PEVQDMKFITPVRRS | 676 | Q8IYA6 | |
| VSRVDPEMRIRFTSP | 361 | Q96SZ6 | |
| MPSRTFIAREEKSVP | 196 | Q96MW7 | |
| DRIMNTFSVVPSPKV | 161 | P04350 | |
| DRIMNTFSVVPSPKV | 161 | P68371 | |
| NKRRIMRIFSVPPTE | 46 | Q96E16 | |
| DRIMNTFSVVPSPKV | 161 | P07437 | |
| VIPLTETKDRPQEMF | 161 | Q96B77 | |
| PEPVDKVAAMREFRV | 101 | Q96S82 | |
| DRIMNTFSVVPSPKV | 161 | Q13509 | |
| TFFRMKVQELQSPPR | 901 | O14795 | |
| KRFFRFTMVTESPNP | 1321 | Q86UU1 | |
| PRQSPEKSHMVFRVE | 16 | Q96L94 | |
| FPEKVDFVRPMRIHT | 86 | P51504 | |
| EVRTFPEVMIPVFDI | 261 | Q14139 | |
| MASFPPRVNEKEIVR | 1 | Q9Y6I7 | |
| FSRVLTPKEMAPTEQ | 251 | P0DMS9 | |
| NDFRSKMQSIFPTIP | 111 | Q9NWH2 |